Companies
Novasep
French specialty CDMO and equipment company (est. 1999) — Hipersep simulated moving bed chromatography, preparative HPLC, multi-column chromatography for mAbs and APIs; strong EU GMP viral clearance and polishing services for biopharmaceutical manufacturers.
- Country
- France
- Revenue
- ~€200M
- Employees
- ~900 emp
GMP EU
ISO 9001
Coverage
| CN | EU | US | |
|---|---|---|---|
| downstream-purification | ✓ | ✓ | ✓ |
Regulatorsfdaema
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | $482 million (2020-01-01) | cen.acs.org |
| Headcount | 1,250 employees (2021-01-01) | cen.acs.org |
| Production site | Chasse-sur-Rhône, France | cen.acs.org · pharmaceutical-technology.com |
| Production site | Mourenx, France | cen.acs.org · pharmaceutical-technology.com |
| Production site | Leverkusen, Germany | cen.acs.org |
| Production site | Le Mans, France | cen.acs.org · pharmaceutical-technology.com |
| Production site | Pompey, France | cen.acs.org · pharmaceutical-technology.com · sec.gov |
| Capacity | 200 m3 small-molecule capacity at Chasse-sur-Rhône | cen.acs.org |
| Capacity | 170 m3 small-molecule capacity at Mourenx | cen.acs.org |
| Capacity | 190 m3 small-molecule capacity at Leverkusen | cen.acs.org |
Independent sources: cen.acs.org · pharmaceutical-technology.com · sec.gov
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Downstream Purification & Bioseparation | downstream-purification | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.